NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Was this really the good news longs were hoping for? Looks muddled to me.

Thanks to the paper, we now know for a fact that the IA had been performed in 2015, Given the PFS results, that would very likely have been a futility rec.

So after getting the futility rec, NWBO changed the trial endpoints.

Admitting the limitations of no patient level data, Talking of the MAIC that attempts to correct, but never presenting that (unless I missed it on first read).

Still no OS between the 233 and 99

EDIT: Strike the last comment on MAIC until I look further.